Clinical trial
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
NCT00195338 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195338 |
|---|---|
| Title | Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg |
| Official title | A Post-Marketing Surveillance Looking At Safety And Adherence To Treatment Of Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Innovex, Inc Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | etanercept |
| Enrollment | 25 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 23, 2012 |
| Countries | Luxembourg |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: